In COVID-19 clinical update #51, Daniel Griffin reviews use of two masks, effectiveness of testing in nursing homes, updates on vaccines, use of nonsteroidal anti-inflammatory drugs, little effect of vitamin D and remdesivir in clinical studies, and a long COVID research initiative from NIH.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• Updated NYC mask guidance (NYC Health)
• Two masks recommended (CDC)
• Effectiveness of testing in nursing homes (Clin Inf Dis)
• Vaccine reactogenicity and antibody response after COVID-19 (medRxiv)
• Bamlanivimab alone or with Etesevimab (JAMA)
• Non-steroidal anti-inflammatory drugs and death (BMJ)
• Budesonide and COVID-19 (medRxiv)
• No effect of vitamin D high dose (JAMA)
• Remdesivir little effect on hospitalized patients (NEJM)
• Sequelae 6 months after infection (JAMA)
• Long COVID initiative (NIH)
• Letters read on TWiV 724
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]